A rigorous, documented approach to how Eloka selects every active ingredient — from initial supplier assessment through final batch release.
Every prospective supplier undergoes a structured review. Chain-of-custody documentation, food-grade processing records, and third-party audit histories are assessed before any ingredient is approved for use.
Ingredient selection is informed by published nutritional research. The editorial team cross-references peer-reviewed studies before a compound enters the formulation pipeline, ensuring each inclusion has documented rationale.
Formulations are assembled with an awareness of nutrient interaction and daily intake balance. No single ingredient is optimised in isolation — the composition is reviewed as a whole against a man's typical active-day profile.
Every production batch is submitted for independent third-party elemental concentration analysis. A certificate of composition accompanies each batch before it is approved for release — no batch ships without this documentation.
Labelling accuracy is verified against the certificate of composition. Once verified, the batch is logged in the release register with a dated entry and revision marker. Documentation is archived for traceability.
Jakarta, 2024
Editorial revision 03-A
Archived June
There is a considered logic to why Eloka's formulations favour mineral complexes and plant-derived concentrates over isolated synthetics. A daily supplement, consumed consistently over months, accumulates its effect not through a single dramatic dose but through the steady repetition of nutritional input.
The sourcing philosophy holds that an ingredient must first be traceable — meaning the supplier can demonstrate provenance from primary cultivation or extraction through to delivery. This eliminates a common weakness in the supplement supply chain, where repackaging between intermediaries obscures the actual origin of a compound.
Plant-based extracts selected for Eloka formulations are standardised to a defined active content range. This means the concentration of the relevant constituent — a polyphenol fraction, a mineral chelate, a B-vitamin precursor — falls within a consistent band across batches. Batch-to-batch variation is one of the most underreported challenges in the food supplement space; standardisation is our primary response to it.
The decision to work with mineral complexes rather than inorganic salts reflects a preference for bioavailability. Chelated mineral forms — where the mineral is bound to an amino acid or organic acid ligand — are absorbed through mechanisms distinct from those used for inorganic salts. The literature on this distinction is consistent and the sourcing decision follows from it directly.
Suppliers are required to provide unbroken documentation from the point of raw material extraction to delivery at the production facility. Gaps in chain-of-custody are grounds for supplier de-listing, regardless of relationship length.
Independent laboratories — selected without supplier input — analyse elemental concentrations and active content for every batch. The laboratory's findings take precedence over supplier certificates of analysis in any discrepancy.
All facilities involved in Eloka's supply chain maintain food-grade processing standards. Records of these standards are reviewed as part of the annual supplier assessment cycle, with on-site verification conducted periodically.
Plant-based concentrates are selected to defined active content specifications. Suppliers are briefed on the target range before contract. Delivered material is verified against that range in the independent batch analysis step.
A permanent batch archive is maintained, with each entry indexed by date, batch code, supplier reference, and verification outcome. This archive forms the traceability backbone of the Eloka production record.
Declared values on product labels are verified against the third-party batch analysis prior to release. Where a result falls outside the declared range, the batch is held pending investigation. No exception is made for commercial timelines.
The Eloka supplier register is a working document, not an administrative archive. Suppliers are added through a defined onboarding sequence and can be suspended or removed at any stage if documentation requirements are not maintained.
An annual review cycle assesses each supplier against updated sourcing standards. Where a supplier's facilities or documentation practices fall below the current threshold, a 60-day remediation period is granted. If remediation is incomplete, the supplier is removed from the register and an alternative source is identified.
Country of origin for all raw materials must be declared and verifiable through primary documentation.
Food-grade processing environments with documented cleaning and contamination-prevention protocols.
A certificate of composition must accompany every delivered lot, with declared values matching ordered specification.
Suppliers must respond to documentation requests within five business days and to discrepancy notices within two.
All active suppliers undergo a formal annual re-assessment. New suppliers are assessed before first order placement.
The Eloka editorial team maintains a reference library of peer-reviewed nutritional studies relevant to men's everyday wellbeing, active performance, and healthy ageing. This library is the primary input into ingredient selection decisions.
Not every study in the library supports inclusion of every ingredient. The team applies a consistent review framework: sample size, duration, funding independence, and replication across multiple studies are all weighted before a finding is considered sufficiently robust to inform formulation.
Where evidence is preliminary or limited to a single study, the ingredient is classified as "under observation" — it may be included in a minor role but is not positioned as a primary formulation element until the evidence base is more established.
Published research from indexed nutritional science journals forms the primary evidentiary basis. Grey literature and industry-funded studies are noted but weighted lower.
A finding is considered sufficiently established for primary formulation use when it has been replicated in at least three independent study populations. Single-study findings are categorised separately.
The reference library is reviewed annually against newly published research. Formulations may be revised in response to updated evidence, with changes logged in the batch release documentation.
Where the evidence base for an ingredient is limited, this is disclosed in the product documentation. Eloka does not present preliminary findings as established consensus.
Eloka is an independent wellness resource focused on everyday nutrition and active lifestyle practices for men. The content is not affiliated with any governmental or institutional body. Ingredient profiles in Eloka supplements are selected based on published nutritional research and undergo independent batch verification for quality and labelling accuracy. We recommend speaking with a qualified wellness or nutrition professional before introducing any supplement to your daily routine, particularly if you have specific dietary requirements.